Catalyst Wire Dossier Catalyst Wire Dossier

PRO-240 ophthalmic solution

PRO-240 · Laboratorios Sophia S.A de C.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PRO-240 ophthalmic solution, covering 2025-03-19 to 2025-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive® [Phase 1]

See pricing